−Removed: than as set forth below, as well as other reports and statements that we have filed with the SEC, there were no material changes from
−Removed: the risk factors set forth under Part I, Item 1A., “Risk Factors” in our Annual Report on Form 10-K for the fiscal year
−Removed: ended December 31, 2024.
−Removed: You should carefully consider the risk factors set forth below and in our Annual Report on Form 10-K for
−Removed: the fiscal year ended December 31, 2024, as well as other reports and statements that we file and have filed with the SEC, in
−Removed: addition to the other information set forth in this report which could materially affect our business, financial condition or future
−Removed: The risks and uncertainties described in this report and in our Annual Report on Form 10-K for the year ended December 31,
−Removed: 2024, as well as other reports and statements that we file with the SEC, are not the only risks and uncertainties facing us.
−Removed: Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also have a material
−Removed: adverse effect on our financial position, results of operations or cash flows.
−Removed: Our prospects are dependent
−Removed: on the successful commercialization of Tonmya.
−Removed: If Tonmya is not commercially successful, our business, financial condition and results of
−Removed: operations may be materially adversely affected and the price of our common stock may decline.
−Removed: not able to successfully commercialize Tonmya.
−Removed: Our inability to commercialize Tonmya may be based on, among other things, lack of adequate
−Removed: coverage or reimbursement from third-party payors, including government health administration authorities, pharmacy benefit managers, managed
−Removed: care organizations and other private health insurers;
−Removed: healthcare legislative or regulatory reform measures;
−Removed: lack of market acceptance;
−Removed: serious adverse events or undesirable side effects;
−Removed: existing, or the introduction of new, products targeting the same or similar indication;
−Removed: the failure to adequately maintain the manufacturing, marketing, sales and distribution channels.
−Removed: Any one or combination of these factors
−Removed: would limit our ability to successfully commercialize Tonmya and would harm our business, financial condition, and results of operations.
−Removed: Unregistered Sales of Equity Securities and Use of Proceeds
+Added: There were no material
+Added: changes from the risk factors set forth under Part I, Item 1A., “Risk Factors” in our Annual Report on Form 10-K for
+Added: the fiscal year ended December 31, 2025.
+Added: You should carefully consider the risk factors set forth in our Annual Report on Form
+Added: 10-K for the fiscal year ended December 31, 2025, as well as other reports and statements that we file and have filed with the
+Added: SEC, in addition to the other information set forth in this report which could materially affect our business, financial condition
+Added: or future results.
+Added: The risks and uncertainties described in this report and in our Annual Report on Form 10-K for the year ended
+Added: December 31, 2025, as well as other reports and statements that we file with the SEC, are not the only risks and uncertainties
+Added: Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also have
+Added: a material adverse effect on our financial position, results of operations or cash flows.
+Added: Unregistered Sales of Equity
+Added: Securities and Use of Proceeds
Purchases of Equity Securities
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.